Stay updated on Autologous NK Cells and Isatuximab Maintenance Clinical Trial
Sign up to get notified when there's something new on the Autologous NK Cells and Isatuximab Maintenance Clinical Trial page.

Latest updates to the Autologous NK Cells and Isatuximab Maintenance Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNew entry Revision: v3.3.3 appears in the record history, and the HHS Vulnerability Disclosure item and Revision: v3.3.2 are removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedThe Record History now includes a new revision entry v3.3.2 and removes revision v3.2.0; this is an administrative update to the history and does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedRemoved a site-wide banner about potential delays due to a lapse in government funding. This notice did not affect the study details or the record history.SummaryDifference0.7%

- Check70 days agoChange DetectedNew version entries were added to the record history documenting changes to study status, recruitment status, and study design, including sponsor/collaborators. The update keeps the trial record current with the latest information.SummaryDifference0.1%

- Check99 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference12%

- Check106 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0, replacing the previous revision tag with a new one.SummaryDifference0.3%

Stay in the know with updates to Autologous NK Cells and Isatuximab Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous NK Cells and Isatuximab Maintenance Clinical Trial page.